Wordwide To Drive The Newborn Metabolic Screening Market At A CAGR Of 9% From 2020-2030

1
Newborn Metabolic Screening Market
Report Id PMRREP31998 Category Life Science
Healthcare
2
About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3
Wordwide To Drive The Newborn Metabolic Screening
Market At A CAGR Of 9 From 2020-2030

• Increasing birth rates across the world are
  expected to drive demand for newborn metabolic
  screening, as the risk of galactosemia, sickle
  cell disease, phenylketonuria, maple syrup urine
  disease, and cystic fibrosis is higher among
  infants. Various countries are implementing
  screening for metabolic diseases in newborns as a
  part of their immunization programs. To remain
  competitive and ensure a robust product pipeline,
  leading companies continue to identify potential
  assets through pilot screening programs, which
  typically have limited resources to see projects
  through the market.
• According to a latest report published by
  Persistence Market Research, the global newborn
  metabolic screening market was valued around US
  247 Mn in 2020, and is expected to witness an
  impressive CAGR of over 9 during the forecast
  period (2020 2030).

Get Sample Copy of Report _at_ https//www.persistenc
emarketresearch.com/samples/31998
4
Collaborations Acquisitions Key Strategies
amongst Market Players

• Leading players in the newborn metabolic
  screening landscape are focusing on improving
  their product portfolios through partnerships and
  acquisitions. Various players are also focusing
  on regulatory approvals and innovative product
  launches.
• On October 05, 2020, PerkinElmer announced CE-IVD
  approval of the EONIS newborn screening assay.
• In October 2018, Trivitrons Labsystems
  Diagnostics launched high quality newborn
  screening panels.
• On September 3, 2020, Sickle SCAN was approved
  by the Department of Health in Australia.

Access Full Report _at_ https//www.persistencemarket
research.com/checkout/31998
5
(No Transcript)